Skip to main content
Glenmark Pharmaceuticals Limited (BOM: 532296)
India flag India · Delayed Price · Currency is INR
1,641.55
+19.15 (1.18%)
At close: Jan 7, 2025

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 34.34B INR in the quarter ending September 30, 2024, with 7.06% growth. This brings the company's revenue in the last twelve months to 130.80B, down -4.88% year-over-year. In the fiscal year ending March 31, 2024, Glenmark Pharmaceuticals had annual revenue of 126.45B with 8.49% growth.

Revenue (ttm)
130.80B
Revenue Growth
-4.88%
P/S Ratio
n/a
Revenue / Employee
8.73M
Employees
14,989
Market Cap
459.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020106.57B7.92B8.03%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,249.38B
Tata Consultancy Services 2,486.92B
HDFC Bank 2,761.06B
Bharti Airtel 1,554.78B
ICICI Bank 1,638.51B
Infosys 1,578.13B
State Bank of India 3,360.28B
Hindustan Unilever 624.10B
Revenue Rankings

Glenmark Pharmaceuticals News

More News